Incision, Otolaryngological Disease, Pain, Postoperative, Surgery
Conditions
Keywords
Virtual Reality
Brief summary
This trial studies an active virtual reality (VR) experience as a means for non-pharmacologic postoperative pain management among patients after head and neck surgery. Investigators will assess differences in pain scores, analgesic use, and subjective patient experiences between patients participating in a VR activity and patients participating in the same activity using a smartphone.
Detailed description
Management of postoperative pain after head and neck surgery is complex, and has received increased attention to improve patient recovery and quality of life. Narcotic analgesics are frequently utilized in postoperative pain management, but these have risks including nausea, sedation, constipation, and dependence. Multimodal analgesia can reduce narcotic use and improve recovery, but medical comorbidities may contraindicate the use of certain medications. Non-pharmacologic measures for postoperative pain control may provide novel and cost-effective strategies to confront this complex issue. Patients undergoing head and neck surgery will be randomly allocated to participate in an immersive experience in VR, or to participate in a similar experience on a two-dimensional screen using a smartphone.
Interventions
DEVICESmartphone
Patients will participate in a similar game to the VR cohort, but will use a smartphone device.
DEVICEVirtual Reality (Oculus Quest)
Patients will participate in a game using VR.
Sponsors
Oregon Health and Science University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients who have undergone head and neck surgery with an average pain score of 3 or greater out of 10 during the 24 hours preceding the screening * Are able to provide informed consent * Are not in the intensive care unit (ICU)
Exclusion criteria
* Symptoms concerning for an active respiratory infection including fever, cough, and shortness of breath or confirmed respiratory infection * Active eye discharge * Active nausea or vomiting * History of seizure, epilepsy, or hypersensitivity to flashing light * History of motion sickness or vertigo * Have wound dressings on the head or neck that prevent comfortable and safe use of the virtual reality headset
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in patient-reported pain scores | Up to 4 hours after intervention use | Pain scores will be obtained using an 11-point Numeric Rating Scale (NRS) prior to each intervention, immediately after the intervention, and then hourly up to 4 hours after the intervention to assess changes in pain scores after each intervention. A score of 0 signifies no pain, and a score of 10 signifies the highest severity of pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Opioid usage | Average 24 hours after intervention use | Opioid use after intervention will be documented, measured in average morphine milligram equivalents (MME). |
| Patient experience | Up to 4 hours after intervention use | Patients will complete a short survey at the completion of their participation in the study evaluating their audiovisual experience using a 5-point Likert scale, with responses ranging from 1 = Strongly Disagree to 5 = Strongly Agree. |
Countries
United States
Outcome results
None listed